Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6149938 | CITIUS PHARMS | Process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets and compositions obtained thereby |
Jul, 2018
(5 years ago) | |
US8440170 | CITIUS PHARMS | Orally disintegrating tablets with speckled appearance |
Mar, 2029
(4 years from now) |
Suprenza is owned by Citius Pharms.
Suprenza contains Phentermine Hydrochloride.
Suprenza has a total of 2 drug patents out of which 1 drug patent has expired.
Expired drug patents of Suprenza are:
Suprenza was authorised for market use on 13 June, 2011.
Suprenza is available in tablet, orally disintegrating;oral dosage forms.
The generics of Suprenza are possible to be released after 14 March, 2029.
Drugs and Companies using PHENTERMINE HYDROCHLORIDE ingredient
Market Authorisation Date: 13 June, 2011
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL